Butt Lane Healthcare Limited 07560576 false 2023-05-01 2024-04-30 2024-04-30 The principal activity of the company is that of a retail pharmacy. Digita Accounts Production Advanced 6.30.9574.0 true true 07560576 2023-05-01 2024-04-30 07560576 2024-04-30 07560576 core:AcceleratedTaxDepreciationDeferredTax 2024-04-30 07560576 core:CurrentFinancialInstruments 2024-04-30 07560576 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 07560576 core:Goodwill 2024-04-30 07560576 core:FurnitureFittingsToolsEquipment 2024-04-30 07560576 core:MotorVehicles 2024-04-30 07560576 bus:SmallEntities 2023-05-01 2024-04-30 07560576 bus:AuditExemptWithAccountantsReport 2023-05-01 2024-04-30 07560576 bus:FilletedAccounts 2023-05-01 2024-04-30 07560576 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 07560576 bus:RegisteredOffice 2023-05-01 2024-04-30 07560576 bus:CompanySecretary1 2023-05-01 2024-04-30 07560576 bus:Director3 2023-05-01 2024-04-30 07560576 bus:Director4 2023-05-01 2024-04-30 07560576 bus:Director5 2023-05-01 2024-04-30 07560576 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 07560576 core:Goodwill 2023-05-01 2024-04-30 07560576 core:FurnitureFittingsToolsEquipment 2023-05-01 2024-04-30 07560576 core:MotorVehicles 2023-05-01 2024-04-30 07560576 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2023-05-01 2024-04-30 07560576 core:ParentEntities 2023-05-01 2024-04-30 07560576 core:UKTax 2023-05-01 2024-04-30 07560576 countries:EnglandWales 2023-05-01 2024-04-30 07560576 2023-04-30 07560576 core:Goodwill 2023-04-30 07560576 core:FurnitureFittingsToolsEquipment 2023-04-30 07560576 core:MotorVehicles 2023-04-30 07560576 2022-05-01 2023-04-30 07560576 2023-04-30 07560576 core:AcceleratedTaxDepreciationDeferredTax 2023-04-30 07560576 core:CurrentFinancialInstruments 2023-04-30 07560576 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-30 07560576 core:Goodwill 2023-04-30 07560576 core:FurnitureFittingsToolsEquipment 2023-04-30 07560576 core:MotorVehicles 2023-04-30 07560576 core:UKTax 2022-05-01 2023-04-30 iso4217:GBP xbrli:pure

Registration number: 07560576

Prepared for the registrar

Butt Lane Healthcare Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 April 2024

 

Butt Lane Healthcare Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 9

 

Butt Lane Healthcare Limited

Company Information

Directors

Mr R Sharda

Mr A Sharda

Mrs N Sharda

Company secretary

Mr R Sharda

Registered office

147 Congleton Road
Butt Lane
Stoke-On-Trent
Staffordshire
ST7 1LL

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Butt Lane Healthcare Limited

(Registration number: 07560576)
Balance Sheet as at 30 April 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

6

31,596

32,130

Current assets

 

Stocks

59,414

53,047

Debtors

7

1,257,308

968,366

Cash at bank and in hand

 

70,688

96,521

 

1,387,410

1,117,934

Creditors: Amounts falling due within one year

8

(341,869)

(272,889)

Net current assets

 

1,045,541

845,045

Total assets less current liabilities

 

1,077,137

877,175

Deferred tax liabilities

10

(6,866)

(6,784)

Net assets

 

1,070,271

870,391

Capital and reserves

 

Called up share capital

100

100

Retained earnings

1,070,171

870,291

Shareholders' funds

 

1,070,271

870,391

For the financial year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 January 2025 and signed on its behalf by:
 


Mr R Sharda
Director

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
147 Congleton Road
Butt Lane
Stoke-On-Trent
Staffordshire
ST7 1LL

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures, fittings and equipment

20% of written down value

Motor vehicles

25% of written down value

Goodwill

Goodwill is amortised over its useful life, estimated by the directors to be 10 years.

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

Tax charged/(credited) in the profit and loss account

2024
£

2023
£

Current taxation

UK corporation tax

86,531

60,720

Deferred taxation

Arising from origination and reversal of timing differences

82

(545)

Tax expense in the income statement

86,613

60,175

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

 

5

Intangible assets

Goodwill
 £

Cost

At 1 May 2023

81,499

At 30 April 2024

81,499

Amortisation

At 1 May 2023

81,499

At 30 April 2024

81,499

Carrying amount

At 30 April 2024

-

At 30 April 2023

-

 

6

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 May 2023

61,168

13,700

74,868

Additions

7,530

-

7,530

Disposals

(1,916)

-

(1,916)

At 30 April 2024

66,782

13,700

80,482

Depreciation

At 1 May 2023

36,744

5,994

42,738

Charge for the year

5,672

1,927

7,599

Eliminated on disposal

(1,451)

-

(1,451)

At 30 April 2024

40,965

7,921

48,886

Carrying amount

At 30 April 2024

25,817

5,779

31,596

At 30 April 2023

24,424

7,706

32,130

 

7

Debtors

2024
£

2023
£

Trade debtors

189,350

133,191

Receivables from related parties

1,028,531

796,284

Prepayments

-

1,297

Other debtors

39,427

37,594

1,257,308

968,366

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

 

8

Creditors

Note

2024
 £

2023
 £

Due within one year

 

Loans and borrowings

9

42,985

-

Trade creditors

 

206,284

207,828

Social security and other taxes

 

879

-

Outstanding defined contribution pension costs

 

655

473

Accrued expenses

 

6,025

5,358

Corporation tax liability

85,041

59,230

 

341,869

272,889


Loans and borrowings include bank overdrafts which are secured against the assets of the company.

 

9

Loans and borrowings

Current loans and borrowings

2024
£

2023
£

Other borrowings

42,985

-

 

10

Deferred tax

Deferred tax assets and liabilities

2024

Liability
£

Capital allowances in excess of depreciation

6,866

6,866

2023

Liability
£

Capital allowances in excess of depreciation

6,784

6,784

 

Butt Lane Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 April 2024

 

11

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company. As at the balance sheet date, the directors were owed £42,985 (2023 - £nil). There are no fixed repayment terms and no interest is charged.
 

Summary of transactions with parent

VPS Sharda Limited
(Parent company of Butt Lane Healthcare Limited)

 During the year VPS Sharda Limited charged rent of £12,600 (2023 - £12,600) and management charges of £nil (2023 - £8,020) to the company. As at 30 April 2024, the company was owed £1,024,491 by VPS Sharda Limited (2023 - £793,499). There are no fixed repayment terms and no interest is charged.

VPS Sharda Property Limited
(A company which shares common directors with Butt Lane Healthcare Limited)
As at 30 April 2024, the company was owed £4,040 by VPS Sharda Property Limited (2023 - £2,785). There are no fixed repayment terms and no interest is charged.